Th1 produce type I cytokines, including IL-2 and IFNγ, facilitating optimal expansion, trafficking, and effector functions of CD8+ T cells, thereby reducing tumor growth and progression [31,36,37]. This evidence concerns the gene CD8A and neoplasm.